go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

Document information 10/03/2010 20:42
Current documents
SPC 2179
PIL 1825
Total: 4004
Submissions in the last 3 months
Updated: 624
New: 87

Welcome to medicines.ie


 

What's New

These are the latest new, updated and retired (removed) Summaries of Product Characteristics (SPCs) and Patient Information Leaflets (PILs) on medicines.ie. More help.

Filter Results

Document Type:
PIL SPC
Status:  
New Update Retired
10 March 2010
New 0, Updated 8, Retired 0, [Total 8]
SPC updated Alimta
Active Ingredients: Pemetrexed disodium
Company: Eli Lilly and Company (Ireland) Limited | Document History
  • Change to section 6 - Pharmaceutical particulars
  • Change to section 6.3 - Shelf life
  • Change to section 10 - Date of revision of the text
PIL updated Brolene 0.1%w/v Eye Drops Solution
Active Ingredients: Propamidine Isethionate
Company: sanofi-aventis | Document History
  • Change due to user-testing of patient information
PIL updated Nozinan Injection
Active Ingredients: levomepromazine hydrochloride
Company: sanofi-aventis | Document History
  • Change due to user-testing of patient information
SPC updated Seroquel Tablets 25mg, 100mg, 200mg and 300mg
Active Ingredients: Quetiapine fumarate
Company: AstraZeneca Pharmaceuticals (Ireland) Ltd | Document History
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
PIL updated Seroquel Tablets 25mg, 100mg, 200mg and 300mg
Active Ingredients: Quetiapine fumarate
Company: AstraZeneca Pharmaceuticals (Ireland) Ltd | Document History
  • Change to warnings or special precautions for use
  • Change to side-effects
PIL updated Seroquel XR 50mg, 200mg, 300mg, 400mg prolonged-release tablets
Active Ingredients: Quetiapine fumarate
Company: AstraZeneca Pharmaceuticals (Ireland) Ltd | Document History
  • Change to warnings or special precautions for use
  • Change to side-effects
SPC updated Seroquel XR 50mg, 200mg, 300mg, 400mg prolonged-release tablets
Active Ingredients: Quetiapine fumarate
Company: AstraZeneca Pharmaceuticals (Ireland) Ltd | Document History
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text
SPC updated ZOCOR Tablets
Active Ingredients: Simvastatin
Company: Merck Sharp & Dohme Ireland (Human Health) Limited | Document History
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 6.1 - List of excipients
09 March 2010
New 0, Updated 7, Retired 0, [Total 7]
PIL updated ACCUPRO TABLETS 5MG, 10MG, 20MG, 40MG
Active Ingredients: Quinapril hydrochloride
Company: Pfizer Healthcare Ireland | Document History
  • Change to information about pregnancy or lactation
SPC updated Acnisal
Active Ingredients: Salicylic Acid
Company: Alliance Pharmaceuticals Ireland | Document History
  • Change to section 6.1 - List of excipients
PIL updated Canesten 100mg Pessary
Active Ingredients: Clotrimazole
Company: Bayer Limited | Document History
  • Change to name of manufacturer
SPC updated Feldene 10mg and 20mg Capsules
Active Ingredients: Piroxicam
Company: Pfizer Healthcare Ireland | Document History
  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text
PIL updated Periostat
Active Ingredients: Doxycycline hyclate
Company: Alliance Pharmaceuticals Ireland | Document History
  • Change to name of manufacturer
SPC updated Sprycel 20mg, 50mg, 70mg and 100mg Film-Coated Tablets
Active Ingredients: dasatinib monohydrate
Company: Bristol-Myers Squibb Pharmaceuticals Ltd | Document History
  • Change to section 6.3 - Shelf life
  • Change to section 10 - Date of revision of the text
PIL updated Sustiva Hard Capsules
Active Ingredients: Efavirenz
Company: Bristol-Myers Squibb Pharmaceuticals Ltd | Document History
  • Introduction of new pack/pack size
08 March 2010
New 0, Updated 8, Retired 0, [Total 8]
PIL updated Clexane Syringes
Active Ingredients: Enoxaparin sodium
Company: sanofi-aventis | Document History
  • Change due to user-testing of patient information
PIL updated Gyno-Pevaryl 150 Vaginal Pessaries
Active Ingredients: Econazole Nitrate
Company: Janssen-Cilag Ltd | Document History
  • Change to date of revision
  • Change to appearance of the medicine
  • Change due to user-testing of patient information
SPC updated Kwells 300 microgram tablets
Active Ingredients: Hyoscine hydrobromide
Company: Bayer Limited | Document History
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.8 - Undesirable effects
  • Change to section 4.9 - Overdose
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 10 - Date of revision of the text
SPC updated Lemsip Max Cold & Flu Hot Lemon 1000mg Powder for Oral Solution
Active Ingredients: Paracetamol
Company: Reckitt Benckiser Ireland Limited | Document History
  • Change to section 1 - Name of medicinal product
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text
SPC updated LYRICA
Active Ingredients: pregabalin
Company: Pfizer Healthcare Ireland | Document History
  • Change to section 4.8 - Undesirable effects
SPC updated Robitussin Dry Cough
Active Ingredients: Dextromethorphan Hydrobromide
Company: Wyeth Consumer Healthcare | Document History
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
SPC updated Robitussin Plus
Active Ingredients: Guaifenesin, Pseudoephedrine Hydrochloride
Company: Wyeth Consumer Healthcare | Document History
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.3 - Contraindications
PIL updated Vascace
Active Ingredients: Cilazapril
Company: Roche Products (Ireland) Ltd | Document History
  • Change due to user-testing of patient information

  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us
logo

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland | Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie